comparemela.com

Latest Breaking News On - Mei pharma - Page 4 : comparemela.com

MEI Pharma, Inc. Announces Dividend of $1.75 (NASDAQ:MEIP)

MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) announced a dividend on Monday, November 6th, NASDAQ reports. Investors of record on Friday, November 17th will be given a dividend of 1.75 per share on Wednesday, December 6th. The ex-dividend date is Thursday, November 16th. MEI Pharma Stock Performance MEIP stock traded down $0.24 during trading […]

Stifel-nicolaus
Pharma-inc
Metlife-investment-management
Mei-pharma-inc
Mirabella-financial-services
Nasdaq
Get-free-report
Life-investment-management
Financial-services
Jane-street-group
Mei-pharma
Nasdaq-meip

MEI Pharma, Inc. (NASDAQ:MEIP) Sees Large Increase in Short Interest

MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totalling 499,000 shares, a growth of 18.8% from the September 30th total of 419,900 shares. Based on an average daily volume of 40,200 shares, the days-to-cover ratio […]

Stifel-nicolaus
Mei-pharma-inc
Securities-exchange-commission
Pharma-inc
Morgan-stanley
Simplex-trading
Nasdaq
Pharma-company-profile
Get-free-report
Exchange-commission
Street-group
Mei-pharma

MEI Pharma (NASDAQ:MEIP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock. Separately, Stifel Nicolaus lowered their price objective on MEI Pharma from $10.00 to $9.00 and set a hold rating on the stock in a […]

Stifel-nicolaus
Securities-exchange-commission
Capital-management
Simplex-trading
Metlife-investment-management
Mirabella-financial-services
Pharma-inc
Free-report
Stock-down
Get-free-report
Exchange-commission
Life-investment-management

MEI Pharma, Inc. (NASDAQ:MEIP) Receives $29.67 Consensus PT from Analysts

MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating on the company. […]

Stifel-nicolaus
Pharma-inc
Nasdaq
Pharma-company-profile
Simplex-trading
Mei-pharma-inc
Morgan-stanley
Get-free-report
Street-group
Get-free
Mei-pharma
Nasdaq-meip

MEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the stock. Separately, Stifel Nicolaus decreased their price target on MEI Pharma from $10.00 to $9.00 and set a hold rating for the company in a research […]

Stifel-nicolaus
Charles-schwab-investment-management-inc
Nasdaq
Goldman-sachs-group-inc
Pharma-inc
Simplex-trading
Pharma-company-profile
Capital-management
Free-report
Stock-down
Sachs-group
Schwab-investment-management

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.